...
首页> 外文期刊>癌と化学療法 >A case of extraovarian primary peritoneal carcinoma successfully treated with weekly paclitaxel
【24h】

A case of extraovarian primary peritoneal carcinoma successfully treated with weekly paclitaxel

机译:每周紫杉醇成功治疗一例卵巢外原发性腹膜癌

获取原文
获取原文并翻译 | 示例

摘要

We report the use of paclitaxel in the successful treatment of a 74-year-old patient with extraovarian primary peritoneal carcinoma and acute renal failure caused by intraperitoneal cisplatin. The histological diagnosis was papillary serous adenocarcinoma. Paclitaxel was given intravenously at 70 mg/m2 in a 1-hour infusion weekly for 6 consecutive weeks followed by 2-weeks rest (one cycle). Toxicities including neutropenia and neurotoxicity were mild. She showed a clinical response after three cycles, and then underwent secondary cytoreductive surgery after which she received one additional cycle of therapy. She enjoyed a favorable quality of life without evidence of disease for 16 months after the completion of this therapy. Weekly 1-hour paclitaxel (70 mg/m2) was well tolerated, yet was effective for extraovarian primary peritoneal carcinoma.
机译:我们报告紫杉醇在成功治疗一名74岁的卵巢外原发性腹膜癌和腹膜内顺铂引起的急性肾衰竭的患者中的使用。组织学诊断为乳头状浆液性腺癌。紫杉醇以70 mg / m2的剂量每周1小时静脉输注,连续6周,然后休息2周(一个周期)。中性粒细胞减少和神经毒性等毒性反应轻微。她在三个周期后显示出临床反应,然后接受了二次细胞减灭术,此后又接受了一个治疗周期。在完成这种治疗后的16个月中,她的生活质量良好,没有疾病迹象。每周1小时紫杉醇(70 mg / m2)的耐受性良好,但对卵巢外原发性腹膜癌有效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号